Search

everythinglearnresearchcommunity

for

Search:↓

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

Immortalized human dermal papilla cells were created that grow better and can still help form hair.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

Patients with thyroid disorders show different symptoms and antibody levels.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Changes in KRT17 gene activity linked to wool production in Angora rabbits.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Trichohyalin may trigger the immune response causing alopecia areata.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

CD34 is a marker for isolating stem-like cells in mouse hair follicles.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Keratins K6 and K16 are expressed more freely in regenerating mouse skin than K1 and K10.

Human thymus has stem cells that can self-renew and maintain their identity.

Certain immune cells may cause hair loss by reacting to stressed hair follicles.

Keratin 19 helps identify skin stem cells, with its presence varying by body location, age, and culture stage.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Thymic mesenchymal cells have unique gene expression that supports their specific functions in the thymus.

Antibodies help identify glycoproteins in normal skin and tumor cells.